Recombinant adenovirus

recombinant adenovirus · CG Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant adenovirus, covering 2021-04-14 to 2021-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer [Phase 2, Phase 3]